research-focus Research Focus International Scientific Journal Research Focus 2181-3833 Ilm-fan va innovatsiyalar akademiyasi 10.66073/researchfocus.v2i1.2881 REL-A-013817 NEW APPROACHESTO TREATMENT OF FUNGAL INFECTIONS AT WOMEN НОВЫЕ ПОДХОДЫ К ЛЕЧЕНИЮ ГРИБКОВЫХ ИНФЕКЦИЙ У ЖЕНЩИН AYOLLARDA ZAMBURUG‘ INFEKSIYALARINI DAVOLASHGA YANGI YONDASHUVLAR F.B. Mirodilova Tashkent Medical Academy F.Kh. Abboskhanova Tashkent Medical Academy Kh.A. Tojimurodov Tashkent Medical Academy 05 02 2023 2023 2 1 369 372 https://creativecommons.org/licenses/by/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.

The article reflects the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Data on the effectiveness of the broad-spectrum antimycotic drug fenticonazole in the treatment of VVC are presented, which makes it possible to increase the effectiveness of treatment and reduce the frequency of relapses of the disease.

В статье отражены основные проблемы диагностики и лечения больных кандидозным вульвовагинитом (ВВК). Представлены данные об эффективности антимикотического препарата широкого спектра действия фентиконазола при лечении ВВК, что позволяет повысить эффективность лечения и снизить частоту рецидивов заболевания.

Maqolada vulvovaginal kandidoz (VVC) bilan og‘rigan bemorlarni tashxislash va davolashning asosiy muammolari yoritilgan. VVCni davolashda keng spektrli antimikotik preparat fentikonazolning samaradorligi haqidagi ma‘lumotlar keltirilgan, bu esa davolash samaradorligini oshirish va kasallik retsidivlari chastotasini kamaytirish imkonini beradi.

 Mendling W. Vulvovaginalmykosen. Klinikum Frankfurt (Oder), AkademischesLehrkrankenhaus der Humboldt–Universitat (Charite) zu Berlin. Z ArztlFortbildQualitatssich 1998; 92 (3): 175���9. Rathod S.D., Klausner J.D., Krupp K., Reingold AL, Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology; 2012. Article ID 859071, 8 p. Rylander E., Berglund A.-L., Krassny C., Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. SexuallyTransmittedInfections. 2004;80:54–57. Urogenital candidiasis. Clinical recommendations. RODViK, ROAG, Utl. Ministry of Health of the Russian Federation 2016. М., 2016. 22с. (in Russ). Literature: Glazkova L.K. Etiology, clinic and therapy of vulvovaginal candidiasis // Obstetrics and gynecology. - 2005. - No. 3. – P. 55–58. Blostein F., Levin-Sparenberg E., Wagner J., Foxman B. Recurrent vulvovaginal candidiasis. Annals of Epidemiology. 2017;27(Suppl. 9):575–582. DOI: 1016/j.annepidem.2017.08.010 Kachalina T.S., Grechkanov G.O., Nikishov N.N. and other 125p . Ozone technologies in obstetrics and gynecology. N. Novgorod. 2007. 292 p. Kubota T. Chronic and recurrent vulvovaginal candidiasis. Dept of Obstetrics and Gynecology, JuntendoUrayasu Hospital, JuntendoUniv, 2–1–1. Tomioka Urayasu-si, Chiba 279–0021. Nippon Ishinkin Gakkai Zasshi 1998; 39(4):213–8. Martyshkina E.Yu. Non-contraceptive effects of hormonal contraception. View of Russian and foreign experts. Obstetrics, gynecology and reproduction. 2011; 3:52-54.